FDA Uses Malvern's Bioequivalence Evaluation Technology

The food and drug administration (FDA) has used Malvern's Morphologi G3-ID system to generate key data for the approval of the first generic nasal spray containing mometasone furoate.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news